ashgrove, yours certainly was an accurate call, well judged.
In view of the importance being given to the approval, imminent or otherwise, of IT in the US I'm puzzled by the lack of substantial takeup of IT so far in Europe where in many countries IT is already approved and in use. Surely if IT was such a quantum leap then Europe would be now be booming as far as sales go even given the fact Europe comprises many different public and private health systems?
This quarterly revenue figure certainly shows any growth in Europe would have been minimal and the nut is certainly proving very hard to crack. Even on a local front in Australia the refusal to use QFTG or IT by the health authorities, particularly in the Eastern states, maybe gives an indication that there is still a long road ahead worldwide.
CST Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
